Literature DB >> 9778185

Postischemic enhancements of N-methyl-D-aspartic acid (NMDA) and non-NMDA receptor-mediated responses in hippocampal CA1 pyramidal neurons.

A Mitani1, S Namba, K Ikemune, H Yanase, T Arai, K Kataoka.   

Abstract

Glutamate receptor-mediated responses were investigated by using a whole-cell recording and an intracellular calcium ion ([Ca2+]i) imaging in gerbil postischemic hippocampal slices prepared at 1, 3, 6, 9, 12, and 24 hours after 5-minute ischemia. Bath application of N-methyl-D-aspartic acid (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), and kainate showed that NMDA-, AMPA- and kainate-induced currents were enhanced in postischemic CA1 pyramidal neurons at 1 to 12 hours after 5-minute ischemia. NMDA and non-NMDA receptor-mediated excitatory postsynaptic currents (EPSC) were examined in postischemic CA1 pyramidal neurons at 3 hours after 5-minute ischemia to confirm whether synaptic responses are enhanced in the postischemic CA1 pyramidal neurons. The amplitudes of NMDA- and non-NMDA-receptor-mediated EPSC were enhanced in the postischemic CA1 pyramidal neurons. NMDA-, AMPA-, and kainate-induced [Ca2+]i elevations were also examined to determine whether the enhancement of currents is accompanied by the enhancement of [Ca2+]i elevation. The enhancements of NMDA-, AMPA-, and kainate-induced [Ca2+]i elevations were shown in the postischemic CA1. These results indicate that NMDA and non-NMDA receptor-mediated responses are persistently enhanced in the CA1 pyramidal neurons 1 to 12 hours after transient ischemia, and suggest that the enhancement of glutamate receptor-mediated responses may act as one of crucial factors in the pathologic mechanism responsible for leading postischemic CA1 pyramidal neurons to irreversible neuronal injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778185     DOI: 10.1097/00004647-199810000-00005

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  7 in total

1.  Modeling glutamatergic synapses: insights into mechanisms regulating synaptic efficacy.

Authors:  Jean-Marie C Bouteiller; Michel Baudry; Sushmita L Allam; Renaud J Greget; Serge Bischoff; Theodore W Berger
Journal:  J Integr Neurosci       Date:  2008-06       Impact factor: 2.117

2.  Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus.

Authors:  T Sugino; K Nozaki; Y Takagi; I Hattori; N Hashimoto; T Moriguchi; E Nishida
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 3.  Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

Review 4.  Hypothermic neuroprotection.

Authors:  A J Gunn; M Thoresen
Journal:  NeuroRx       Date:  2006-04

5.  Tyrosine phosphorylation of GluK2 up-regulates kainate receptor-mediated responses and downstream signaling after brain ischemia.

Authors:  Qiu-Ju Zhu; Fan-Shu Kong; Hao Xu; Yi Wang; Cai-Ping Du; Chang-Cheng Sun; Yong Liu; Ting Li; Xiao-Yu Hou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

6.  Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors.

Authors:  Lindsay M Achzet; Fanny Astruc-Diaz; Phillip H Beske; Nicholas R Natale; Travis T Denton; Darrell A Jackson
Journal:  Pharmaceutics       Date:  2021-04-30       Impact factor: 6.321

7.  Oxidative Stress Underlies the Ischemia/Reperfusion-Induced Internalization and Degradation of AMPA Receptors.

Authors:  Lindsay M Achzet; Clara J Davison; Moira Shea; Isabella Sturgeon; Darrell A Jackson
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.